PURE Bioscience Ships Initial Order to Italian Export Consortium, TICE
2013年6月7日 - 9:31PM
Marketwired
PURE Bioscience, Inc. (OTCQB: PURE), the
creator of the patented silver dihydrogen citrate (SDC)
antimicrobial, shipped an opening order of PURE Hard Surface and
PURE Multi-Purpose Cleaner Concentrate to European distributor and
Italian export consortium, TICE.
"We have placed this order as part of our initial campaign of
customer trials and evaluation," said Dosolino Marangon, president
of TICE. "We have been receiving a positive response to our
education and marketing campaigns for PURE products, and anticipate
a successful product launch in Italy followed by introductions in
more than 25 additional European countries."
Since PURE announced its partnership with TICE in September
2012, TICE has been pursuing the necessary REACH requirements to
distribute PURE's disinfecting and cleaning products in the
European Union. REACH, which stands for registration, evaluation,
authorization and restriction of chemicals, represents the European
Community's regulation on chemicals and their safe use. REACH also
mandates the progressive substitution of the most dangerous
chemicals when suitable alternatives have been identified. TICE has
filed the REACH pre-registration of PURE Hard Surface, PURE
Multi-Purpose cleaner concentrate and PURE Floor Cleaner with the
European Chemical Agency (ECHA), authorizing TICE by European law
to import and distribute PURE Products throughout Europe.
"This shipment and the REACH filing are milestone events for our
company," said Michael L. Krall, PURE Bioscience's president and
CEO. "We appreciate the time, resources and investment TICE has
committed to gain regulatory clearance for distribution of PURE
products in Italy and elsewhere in Europe. We look forward to this
first commercial launch of PURE across Europe."
About TICE TICE (The Italian Consortium
Export) is a consortium composed of Italian companies who have as
their main philosophy the promotion and sale of 100% made-in-Italy
products, with an emphasis on the North American market. The
product categories for TICE marketing include food and wine,
production and process systems, renewable energy process systems,
hospitality and restaurant decoration and design. Started on an
experimental level in 2002, the TICE Consortium was officially
founded in 2004 with a small number of companies. Over the years
this number has grown, which has allowed TICE to create a network
of business relationships in Italy, the United States and Mexico to
execute innovative business concepts. For more information about
TICE, visit www.tice.it.
About PURE Bioscience, Inc. PURE
Bioscience, Inc. develops and markets technology-based bioscience
products that provide solutions to numerous global health
challenges, including Staph (MRSA) and Carbapenem-resistant
Enterobacteriaceae (CRE)/NDM-1+. PURE's proprietary high
efficacy/low toxicity bioscience technologies, including its silver
dihydrogen citrate-based antimicrobials, represent innovative
advances in diverse markets and lead today's global trend toward
industry and consumer use of "green" products while providing
competitive advantages in efficacy and safety. Patented SDC is an
electrolytically generated source of stabilized ionic silver, which
formulates well with other compounds. As a platform technology, SDC
is distinguished from competitors in the marketplace because of its
superior efficacy, reduced toxicity and the inability of bacteria
to form a resistance to it. PURE is headquartered in El Cajon,
California (San Diego metropolitan area). Additional information on
PURE is available at www.purebio.com.
About PURE Hard Surface US EPA registered
PURE Hard Surface disinfectant and food contact surface sanitizer
provides an unparalleled combination of high efficacy and low
toxicity with 30-second bacterial and viral kill times and 24-hour
residual protection. SDC-based PURE Hard Surface completely kills
resistant pathogens like MRSA and Carbapenem-resistant Klebsiella
pneumoniae (NDM-1) and also effectively eliminates dangerous fungi
and viruses including HIV, Hepatitis B, Hepatitis C, Norovirus,
Influenza A, Avian Influenza and H1N1 as well as hazardous food
pathogens such as E. coli, Salmonella and Campylobacter. PURE Hard
Surface delivers powerful broad-spectrum efficacy while remaining
classified as least-toxic (Category IV) by the US EPA, and its
active ingredient, SDC, has been determined Generally Recognized as
Safe (GRAS) for use as a biocide on food processing equipment,
machinery and utensils.
About PURE Floor Cleaner and Multi-Purpose
Concentrates PURE's non-toxic, environmentally responsible
cleaning products are protected by SDC, a natural, non-toxic
antimicrobial. SDC ensures the quality and safety of PURE Floor
Cleaner and PURE Multi-Purpose Cleaner without human or
environmental exposure to toxic chemical preservatives. PURE Floor
Cleaner and PURE Multi-Purpose cleaner are non-flammable and
contain no EDTA, phosphates, ammonia or bleach as well as no VOCs
or NPEs. PURE Floor Cleaner and PURE Multi-Purpose Cleaner provide
professional strength cleaning in a concentrate formula that yields
a 1:128 use dilution that is safe for use on all resilient
surfaces. The active ingredients in the cleaner products meet the
US EPA's DfE (Design for the Environment) Criteria for Safer
Chemical Ingredients.
Forward-looking Statements This press
release includes statements that may constitute "forward-looking"
statements, usually containing the words "believe," "estimate,"
"expect," "intend," "project" or similar expressions. These
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such
differences include, but are not limited to, the Company's cash
position and liquidity requirements, the Company's failure to
implement or otherwise achieve the benefits of its proposed
initiatives and business plans, acceptance of the Company's current
and future products and services in the marketplace, the ability of
the Company to develop effective new products and receive
regulatory approvals of such products, competitive factors,
dependence upon third-party vendors, and other risks detailed in
the Company's periodic report filings with the Securities and
Exchange Commission. By making these forward-looking statements,
the Company undertakes no obligation to update these statements for
revisions or changes after the date of this release.
Investor Relations Contact: Ron Both Liolios Group, Inc.
Tel 949-574-3860 Email Contact
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 6 2024 まで 7 2024
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 7 2023 まで 7 2024